Halt In US HIV Funds Could Cost S.Africa 500000 Lives Over 10 Years
|
A halt in US funds to South Africa's HIV/AIDS
programmes could lead to more than 500,000 deaths over 10 years, the head of
the leading Desmond ... |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...